Literature DB >> 33200769

Efficacy of Ustekinumab for Active Perianal Fistulizing Crohn Disease: A Double-Center Cohort Study.

Mohamed Attauabi1,2,3, Johan Burisch1,2, Jakob Benedict Seidelin3.   

Abstract

Entities:  

Keywords:  perianal fistulizing Crohn disease; ustekinumab

Mesh：

Substances：

Year:  2021        PMID： 33200769     DOI： 10.1093/ibd/izaa297

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN： 1078-0998            Impact factor:   5.325


× No keyword cloud information.
  6 in total

Review 1.  How to Optimize Treatment With Ustekinumab in Inflammatory Bowel Disease: Lessons Learned From Clinical Trials and Real-World Data.

Authors:  Ana Gutiérrez; Iago Rodríguez-Lago
Journal:  Front Med (Lausanne)       Date:  2021-01-28

2.  Ustekinumab is effective for perianal fistulising Crohn's disease: a real-world experience and systematic review with meta-analysis.

Authors:  Gala M Godoy Brewer; George Salem; Muhammad A Afzal; Berkeley N Limketkai; Zadid Haq; Maryam Tajamal; Joanna Melia; Mark Lazarev; Florin M Selaru; Alyssa M Parian
Journal:  BMJ Open Gastroenterol       Date:  2021-12

3.  Successful Non-Operative Treatment of Enterovesical and Enterocutaneous Fistulas Due to Crohn's Disease.

Authors:  Hui Li; Lu Xie; Hongdi Yao; Lexing Zhang; Sanhong Liang; Wen Lyu
Journal:  Int Med Case Rep J       Date:  2022-03-29

4.  Effectiveness of ustekinumab in patients with refractory Crohn's disease: a multicentre real-life study in Italy.

Authors:  Maria Lia Scribano; Annalisa Aratari; Benedetto Neri; Cristina Bezzio; Paola Balestrieri; Valentina Baccolini; Giuliano Falasco; Caterina Camastra; Paolo Pantanella; Rita Monterubbianesi; Alessandro Tullio; Simone Saibeni; Claudio Papi; Livia Biancone; Rocco Cosintino; Roberto Faggiani
Journal:  Therap Adv Gastroenterol       Date:  2022-02-14       Impact factor: 4.409

Review 5.  Management of Non-response and Loss of Response to Anti-tumor Necrosis Factor Therapy in Inflammatory Bowel Disease.

Authors:  Jan Marsal; Manuel Barreiro-de Acosta; Irina Blumenstein; Maria Cappello; Thomas Bazin; Shaji Sebastian
Journal:  Front Med (Lausanne)       Date:  2022-06-15

Review 6.  Managing complex perianal disease after anti-TNF failure: Where to go next?

Authors:  Clare Yzet; Franck Brazier; Charles Sabbagh; Mathurin Fumery
Journal:  Curr Res Pharmacol Drug Discov       Date:  2022-01-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.